| Serial Number | 98421438 |
| Word Mark | WTC@H?! |
| Filing Date | Monday, February 26, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, April 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 8, 2025 |
| Goods and Services | Promoting awareness of congenital adrenal hyperplasia by providing a public online platform in the nature of an online forum to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency by providing a public online platform in the nature of an online forum to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders by providing a public online platform in the nature of an online forum to discuss endocrine diseases and disorders and coping strategies |
| Pseudo Mark | WTC AT H |
| Goods and Services | Promoting awareness of congenital adrenal hyperplasia and promoting awareness of congenital adrenal hyperplasia by providing a public in-person platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and promoting awareness of adrenal insufficiency by providing a public in-person platform to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders and promoting awareness of endocrine diseases and disorders by providing a public in-person platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders |
| Goods and Services | Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders |
| Goods and Services | Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 26, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 038 - Services allowing people to communicate with another by a sensory means. |
| US Class Codes | 100, 101, 104 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 26, 2024 |
| Primary Code | 038 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 26, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Monday, February 26, 2024 | NEW APPLICATION ENTERED |
| Friday, July 5, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 15, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, August 28, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 12, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, November 12, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, February 27, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 7, 2025 | ASSIGNED TO LIE |
| Monday, March 10, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 10, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 14, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 14, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, March 14, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, March 14, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, March 14, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 14, 2025 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, March 20, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, March 20, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, March 20, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, August 28, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 28, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 2, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 8, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 8, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |